NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHGRI E-044-2013-0-EP-04 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) EP National Stage 12806796.4 Issued
NHGRI E-044-2013-0-IE-13 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) IE EP 12806796.4 Issued
NHGRI E-044-2013-0-GB-12 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) GB EP 12806796.4 Issued
NHGRI E-044-2013-0-CH-09 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) CH EP 12806796.4 Issued
NHGRI E-044-2013-0-NL-14 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) NL EP 12806796.4 Issued
NHGRI E-044-2013-0-DE-10 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) DE EP 12806796.4 Issued
NHGRI E-044-2013-0-FR-11 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) FR EP 12806796.4 Issued
NHGRI E-044-2013-0-JP-05 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin JP National Stage 2014-546152 Abandoned
NHGRI E-044-2013-0-US-02 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) US ORD 13/708,709 9326992 Issued PDF
NCI E-181-2012-0-PCT-02 TUMOR-SPECIFIC GM-CSF CYTOKINE RESPONSE AS PREDICTOR OF CANCER VACCINE EFFECTIVENESS PCT PCT PCT/US2012/068574 Expired
NHGRI E-044-2013-0-PCT-03 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) PCT PCT PCT/US2012/068609 Expired
NCI E-181-2012-0-EP-03 TUMOR-SPECIFIC GM-CSF CYTOKINE RESPONSE AS PREDICTOR OF CANCER VACCINE EFFECTIVENESS EP National Stage 12855305.4 Abandoned
NIDDK E-129-2010-0-US-04 Programmable Self-Assembled Nanostructures Based On Sidechain-Modified PNA For The Multivalent Display Of Ligands US National Stage 13/697,123 Abandoned
NIA E-237-2014-1-US-01 Cerium Oxide Nanoparticles And Associated Methods For Promoting Wound Healing US ORD 13/706,973 Abandoned
NIDDK E-129-2010-0-FR-05 Programmable Self-Assembled Nanostructures Based On Sidechain-Modified PNA For The Multivalent Display Of Ligands FR EP 11721899.0 Issued
NIDDK E-129-2010-0-DE-06 Programmable Self-Assembled Nanostructures Based On Sidechain-Modified PNA For The Multivalent Display Of Ligands DE EP 11721899.0 Issued
NIDDK E-129-2010-0-IE-08 Programmable Self-Assembled Nanostructures Based On Sidechain-Modified PNA For The Multivalent Display Of Ligands IE EP 11721899.0 Issued
NIDDK E-129-2010-0-GB-07 Programmable Self-Assembled Nanostructures Based On Sidechain-Modified PNA For The Multivalent Display Of Ligands GB EP 11721899.0 Issued
NINDS E-043-2012-0-PCT-02 SYSTEM AND METHOD OF AUTOMATICALLY DETECTING TISSUE ABNORMALITIES PCT PCT PCT/US2012/067997 Expired
NIAID E-139-2006-0-US-11 Development Of Dengue Virus Vaccine Components US DIV 13/692,557 9090873 Issued PDF
NCI E-058-2015-1-PCT-01 MATERIALS AND METHODS RELATED TO NSAID CHEMOPREVENTION IN COLORECTAL CANCER PCT PCT COMB PCT/US2012/067651 Expired
NIAID E-066-2003-5-US-05 Monoclonal Antibodies That Bind Or Neutralize Dengue Virus US DIV 13/692,521 Abandoned
NIBIB E-005-2012-1-US-01 Multi-Focal Structured Illumination Microscopy Systems and Methods US 61/732,460 Abandoned
NCI E-058-2015-1-AU-02 MATERIALS AND METHODS RELATED TO NSAID CHEMOPREVENTION IN COLORECTAL CANCER AU National Stage 2012346899 Abandoned
NCI E-058-2015-1-CA-05 MATERIALS AND METHODS RELATED TO NSAID CHEMOPREVENTION IN COLORECTAL CANCER CA National Stage 2857712 Abandoned
NIAID E-575-2013-2-PCT-01 VACCINE FOR FALCIPARUM MALARIA PCT PCT COMB PCT/US2012/067404 Expired
NIDA E-249-2012-0-US-01 Therapeutic Polypeptides and Methods of Their Use US 61/732,241 Abandoned
NCATS E-277-2011-1-PCT-01 Modulators Of Lipid Storage PCT PCT COMB PCT/US2012/066394 Expired
NIBIB E-066-2012-0-US-01 Nanoparticles For Delivery Of Ligands US 61/729,159 Abandoned
NCI E-173-2012-2-EP-02 Use of PDL1 Expressing Cells to Convert T Cells Into Regulatory Cells EP National Stage 12851070.8 Issued
NIAID E-323-2005-2-AU-12 Influenza Hemagglutinin And Neuraminidase Variants AU DIV 2012258291 Abandoned
NCI E-173-2012-2-PCT-01 USE OF PDL1 EXPRESSING CELLS TO CONVERT T CELLS INTO REGULATORY T CELLS PCT PCT COMB PCT/US2012/066112 Expired
NCI E-281-2012-0-US-01 INHIBITORS OF THE T CELL-SPECIFIC ALTERNATIVE P38 ACTIVATION PATHWAY AND METHODS OF USE US 61/728,368 Abandoned
NICHD E-016-2013-0-US-01 Assay To Measure Midkine Or Pleiotrophin Level For Diagnosing A Growth US 61/728,624 Abandoned
NCI E-039-2012-2-EP-06 Auto-recognizing Therapeutic R/DNA Chimeric Nanoparticles (NP) EP National Stage 12795973.2 Issued
NCI E-039-2012-2-GB-07 Auto-recognizing Therapeutic R/DNA Chimeric Nanoparticles (NP) GB EP 12795973.2 Issued
NIDA E-221-2010-0-US-03 Phenylmorpholines And Analogues Thereof US ORD 13/698,892 9617229 Issued PDF
NCI E-039-2012-2-JP-04 Auto-recognizing Therapeutic R/DNA Chimeric Nanoparticles (NP) JP National Stage 2014-542565 Issued
NCI E-039-2012-2-PCT-01 Auto-recognizing Therapeutic R/DNA Chimeric Nanoparticles (NP) PCT PCT PCT/US2012/065945 Expired
NCI E-038-2012-2-PCT-01 Therapeutic RNA Switches Compositions and Methods of Use PCT PCT PCT/US2012/065932 Expired
NCI E-038-2012-2-EP-04 Therapeutic RNA Switches Compositions and Methods of Use EP National Stage 12795971.6 Abandoned
NCI E-038-2012-2-JP-05 Therapeutic RNA Switches Compositions and Methods of Use JP National Stage 2014-542562 Abandoned
NCI E-038-2012-2-AU-02 Therapeutic RNA Switches Compositions and Methods of Use AU National Stage 2012340086 Abandoned
NCI E-039-2012-2-AU-02 Auto-recognizing Therapeutic R/DNA Chimeric Nanoparticles (NP) AU National Stage 2012340094 Abandoned
NCI E-038-2012-2-CA-03 Therapeutic RNA Switches Compositions and Methods of Use CA National Stage 2856116 Abandoned
NCI E-039-2012-2-CA-03 Auto-recognizing Therapeutic R/DNA Chimeric Nanoparticles (NP) CA National Stage 2856117 Pending
NCI E-255-2011-0-PCT-02 A METHOD FOR POSTIVELY OR NEGATIVELY REGULATING THE ASSEMBLY OF NEWLY SYNTHESIZED CENP-A TO EXOGENOUS ALPHOID DNA CONTAINING CENP-B BOXES IN MAMMALIAN CELL LINES PCT PCT PCT/JP2012/007384 Expired
NCATS E-134-2010-0-US-07 Inhibitors of Human 12-Lipoxygenase US National Stage 13/698,340 Abandoned
NCATS E-148-2012-0-US-01 Tocopherol Analogues As Correctors Of Lysosomal Storage Disorders US 61/727,296 Abandoned
NCI E-201-2012-0-US-01 Methods of Treating Patients Infected With HIV and HTLV US 61/726,975 Abandoned